Strata Skin Sciences - 8 Year Stock Split History | SSKN
Stock split history for Strata Skin Sciences since 2016. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
| Strata Skin Sciences Annual Stock Splits |
|---|
| Strata Skin Sciences Quarterly Stock Splits |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.018B | $0.033B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $38.875B | 21.62 |
| Inspire Medical Systems (INSP) | United States | $7.378B | 0.00 |
| 10x Genomics (TXG) | United States | $3.475B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.470B | 0.00 |
| Axonics (AXNX) | United States | $3.427B | 0.00 |
| Enovis (ENOV) | United States | $3.084B | 23.43 |
| Azenta (AZTA) | United States | $2.854B | 232.59 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.772B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.659B | 0.00 |
| Privia Health (PRVA) | United States | $2.118B | 93.95 |
| Schrodinger (SDGR) | United States | $1.811B | 0.00 |
| Phreesia (PHR) | United States | $1.306B | 0.00 |
| Omnicell (OMCL) | United States | $1.206B | 29.52 |
| Definitive Healthcare (DH) | United States | $0.847B | 0.00 |
| Standard BioTools (LAB) | United States | $0.757B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Talkspace (TALK) | United States | $0.497B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.329B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.316B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.308B | 0.00 |
| Pulmonx (LUNG) | United States | $0.286B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.171B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.158B | 0.00 |
| Augmedix (AUGX) | United States | $0.155B | 0.00 |
| American Well (AMWL) | United States | $0.149B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.131B | 0.00 |
| TruBridge (TBRG) | United States | $0.122B | 5.19 |
| Outset Medical (OM) | United States | $0.112B | 0.00 |
| 111 (YI) | China | $0.081B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.076B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.076B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.051B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.042B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Movano (MOVE) | United States | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Cue Health (HLTH) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| ETAO (ETAO) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.019B | 0.00 |
| Akili (AKLI) | United States | $0.017B | 0.00 |
| Centogene (CNTG) | Germany | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |